GoodRx Holdings, Inc. (GDRX)
USD 4.37
(-2.02%)
USD 4.37
(-2.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 750.26 Million | 766.55 Million | 745.42 Million | 550.7 Million | 388.22 Million | 249.52 Million |
| Cost of Revenue | 66.92 Million | 65.07 Million | 46.71 Million | 29.58 Million | 14.01 Million | 6.03 Million |
| Gross Profit | 683.34 Million | 701.47 Million | 698.7 Million | 521.11 Million | 374.2 Million | 243.48 Million |
| Operating Expenses | 710.34 Million | 699.73 Million | 685.3 Million | 796.83 Million | 234.53 Million | 166.23 Million |
| Selling, General and Administrative Expenses | 466.84 Million | 502.42 Million | 524.9 Million | 716.58 Million | 191.65 Million | 112.53 Million |
| Research and Development Expenses | 135.83 Million | 143.13 Million | 125.86 Million | 61.81 Million | 29.3 Million | 43.89 Million |
| Other Expenses | 107.66 Million | 54.17 Million | 34.53 Million | 18.43 Million | 13.57 Million | -7000.00 |
| Cost and Expenses | 777.27 Million | 764.81 Million | 732.01 Million | 826.41 Million | 248.54 Million | 172.27 Million |
| Operating Income | -27 Million | 11.01 Million | 13.4 Million | -275.71 Million | 139.67 Million | 77.25 Million |
| Interest Expense | 56.72 Million | 34.24 Million | 23.64 Million | 27.91 Million | 49.56 Million | 22.19 Million |
| Income Tax Expense | -46.7 Million | 9.59 Million | 15.07 Million | -9.82 Million | 16.93 Million | 8.55 Million |
| Earnings before Tax | -55.57 Million | -23.23 Million | -10.17 Million | -303.45 Million | 82.97 Million | 52.34 Million |
| Net Income | -8.86 Million | -32.82 Million | -25.25 Million | -293.62 Million | 66.04 Million | 43.79 Million |
| Earnings Per Share Basic | -0.02 | -0.08 | -0.06 | -0.75 | 0.11 | 0.12 |
| Earnings Per Share Diluted | -0.02 | -0.08 | -0.06 | -0.75 | 0.11 | 0.12 |
| Weighted Average Shares Outstanding | 410.31 Million | 412.85 Million | 400.56 Million | 391.66 Million | 385.38 Million | 356.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 410.31 Million | 412.85 Million | 400.56 Million | 391.66 Million | 385.38 Million | 362.6 Million |
| Gross Margin | 0.91 | 0.92 | 0.94 | 0.95 | 0.96 | 0.98 |
| EBIT Margin | 0.15 | 0.09 | 0.06 | -0.47 | 0.39 | 0.35 |
| Profit Margin | -0.01 | -0.04 | -0.03 | -0.53 | 0.17 | 0.18 |
| EBITDA | 108.82 Million | 68.53 Million | 48 Million | -257.1 Million | 148.27 Million | 84.34 Million |
| Earnings Before Tax Margin | -0.04 | 0.01 | 0.02 | -0.50 | 0.36 | 0.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 200.61 Million | 197.88 Million | 196.64 Million | 750.26 Million | 179.95 Million | 189.67 Million |
| Cost of Revenue | 28.83 Million | 28.41 Million | 57.5 Million | 170.09 Million | 18.72 Million | 16.33 Million |
| Gross Profit | 171.77 Million | 169.47 Million | 139.13 Million | 580.17 Million | 161.23 Million | 173.33 Million |
| Operating Expenses | 151.15 Million | 149.04 Million | 154.58 Million | 528.79 Million | 199.56 Million | 155.03 Million |
| Selling, General and Administrative Expenses | 120.3 Million | 118.02 Million | 123.05 Million | - | 126.93 Million | 107.64 Million |
| Research and Development Expenses | 30.85 Million | 31.01 Million | 31.53 Million | - | 39.61 Million | 31.28 Million |
| Other Expenses | 16.96 Million | 15.94 Million | 43.6 Million | -4 Million | -2.2 Million | 16.09 Million |
| Cost and Expenses | 179.99 Million | 177.45 Million | 212.09 Million | 698.88 Million | 218.28 Million | 171.36 Million |
| Operating Income | 20.61 Million | 20.43 Million | -15.45 Million | 51.37 Million | -38.33 Million | 18.3 Million |
| Interest Expense | 14.56 Million | 14.64 Million | 14.82 Million | 56.72 Million | 14.72 Million | 14.05 Million |
| Income Tax Expense | 4.95 Million | 1.3 Million | 1.23 Million | -46.7 Million | -8.1 Million | -46.71 Million |
| Earnings before Tax | 11.64 Million | 293 Thousand | -24.63 Million | -55.57 Million | -46.6 Million | 12.06 Million |
| Net Income | 6.69 Million | -1 Million | -25.86 Million | -8.86 Million | -38.49 Million | 58.78 Million |
| Earnings Per Share Basic | 0.02 | -0.00 | -0.06 | - | -0.09 | 0.14 |
| Earnings Per Share Diluted | 0.02 | -0.00 | -0.06 | - | -0.09 | 0.14 |
| Weighted Average Shares Outstanding | 376.25 Million | 390.04 Million | 403.24 Million | 410.31 Million | 413.43 Million | 412.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 384.73 Million | 390.04 Million | 403.24 Million | 410.31 Million | 413.43 Million | 414.33 Million |
| Gross Margin | 0.86 | 0.86 | 0.71 | 0.77 | 0.90 | 0.91 |
| EBIT Margin | 0.19 | 0.18 | 0.15 | - | 0.01 | 0.22 |
| Profit Margin | 0.03 | -0.01 | -0.13 | -0.01 | -0.21 | 0.31 |
| EBITDA | 37.58 Million | 36.37 Million | 29.23 Million | - | 1.14 Million | 42.21 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | -0.08 | 0.07 | -0.21 | 0.10 |
FPT
2114
NPSGY
ISLCONSUL
PAT
ARENTERP